Composite micro-nano fiber membrane material with shish-kebab structure as well as preparation method and application of composite micro-nano fiber membrane material

By introducing a string crystal structure and antibacterial agent into the polycaprolactone material, the problem of insufficient hydrophobicity and antibacterial properties is solved, and better cell adhesion and antibacterial effects are achieved, which is suitable for tissue engineering and wound treatment.

CN118987360APending Publication Date: 2024-11-22WUYI UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410932317.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-12
Publication Date
2024-11-22

Smart Images

  • Figure HDA0004940095850000011
    Figure HDA0004940095850000011
  • Figure HDA0004940095850000021
    Figure HDA0004940095850000021
  • Figure HDA0004940095850000022
    Figure HDA0004940095850000022
Patent Text Reader

Abstract

The invention discloses a composite micro-nanofiber membrane material with a shish-kebab structure and a preparation method and application thereof, and belongs to the technical field of tissue engineering. The composite micro-nanofiber membrane material is prepared from the following raw materials: polycaprolactone, a dopamine hydrochloride solution and an antibacterial agent, wherein the composite micro-nanofiber membrane material is of a shish-kebab structure which is spirally arranged in a staggered mode in the diameter direction of nanofibers. The spinning membrane is subjected to self-induced crystallization by using a dilute solution of polycaprolactone, and the crystallized membrane material is subjected to surface modification by utilizing an adsorption effect, so that the hydrophilicity of the composite micro-nano fiber membrane material is greatly improved, and the antibacterial activity of the composite micro-nano fiber membrane material is also improved; the composite micro-nano fiber membrane material with the shish-kebab structure has the potential of being applied to the field of guided tissue regeneration.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of tissue engineering, and in particular to a composite micro-nano fiber membrane material with a shish-kebab structure, and a preparation method and application thereof. Background Art

[0002] Polycaprolactone (PCL) is a semi-crystalline polymer with good thermal and chemical stability. It also has good biocompatibility and biodegradability, is less irritating to human tissues, and can be slowly degraded in the body. Its degradation rate can be controlled to a certain extent by adjusting the molecular weight. So far, polycaprolactone has been widely used in drug sustained-release carriers, tissue engineering scaffolds, bone graft substitutes, and other tissue engineering applications. There have been a lot of studies on the biocompatibility of polycaprolactone and its in vivo and in vitro degradability and toxicity. Because PCL is a flexible, rubber-like soft and elastic material, it is suitable for tissue repair membranes and other wound treatments. A variety of medical devices and drug sustained-release materials using polycaprolactone as raw materials have been approved by the US Food and Drug Administration.

[0003] However, polycaprolactone itself has the following problems: strong hydrophobicity. PCL material is highly hydrophobic, which leads to poor cell adhesion on its surface, which is not conducive to cell growth and tissue regeneration; poor cell adhesion. Due to the lack of biological activity, PCL fiber membrane can hardly effectively support cell adhesion and proliferation; insufficient antibacterial performance. In some applications, especially wound dressings and tissue engineering scaffolds, materials need to have certain antibacterial properties to prevent infection, but PCL itself lacks this function.

[0004] Therefore, it is necessary to provide a composite micro-nano fiber membrane material with hydrophilicity and antibacterial activity to solve the above problems. Summary of the invention

[0005] The present invention aims to solve at least one of the technical problems existing in the prior art. To this end, the present invention provides a composite micro-nano fiber membrane material with a shish-kebab structure, which has an obvious shish-kebab structure and good hydrophilicity and antibacterial activity.

[0006] The present invention also provides a method for preparing the composite micro-nano fiber membrane material.

[0007] The present invention also provides application of the composite micro-nano fiber membrane material.

[0008] The first aspect of the present invention provides a composite micro-nano fiber membrane material having a shish-kebab structure, wherein the raw materials for preparing the composite micro-nano fiber membrane material include polycaprolactone, dopamine hydrochloride solution and an antibacterial agent;

[0009] Wherein, the composite micro-nano fiber membrane material is a shredded crystal structure which is arranged in a spiral staggered manner along the diameter direction of the nanofiber.

[0010] The composite micro-nano fiber membrane material according to the embodiment of the present invention has at least the following beneficial effects:

[0011] The composite micro-nano fiber membrane material described in the present invention has an obvious shish-kebab structure, which is similar to the "D periodic" structure formed by the spirally arranged collagen molecules on the surface of the collagen fibers in the extracellular matrix. The shish-kebab structure described in the present invention is spirally arranged along the diameter direction of the nanofiber, which further increases the specific surface area of ​​the nanofiber, enhances the hydrophilicity of the fiber membrane, and is beneficial to the adhesion, proliferation, migration and other activities of cells.

[0012] The present invention uses a dilute solution of polycaprolactone to carry out self-induced crystallization on the spinning membrane, and utilizes adsorption to modify the surface of the crystallized membrane material, thereby obtaining a fiber membrane with a shredded crystal microstructure, thereby increasing the specific surface area of ​​the membrane, thereby not only greatly improving the hydrophilicity of the polycaprolactone membrane material, but also giving the membrane material a certain antibacterial effect. Under the same conditions, the antibacterial effect of the membrane material is improved, and the more obvious the shredded crystal structure, the better the antibacterial activity.

[0013] The preparation method of the present invention is simple and easy, and the formula can be flexibly adjusted according to the actual application scenario. The prepared composite micro-nano fiber membrane material with a shuffle structure has the potential to be applied in the field of guided tissue regeneration.

[0014] According to some embodiments of the present invention, the lamellae size of the shish-kebab structure is 10 nm to 700 nm.

[0015] Preferably, the lamellae size of the shish-kebab structure is 10 nm to 400 nm.

[0016] According to some embodiments of the present invention, the periodic distance of the shish-kebab structure is 20 nm to 2000 nm.

[0017] Preferably, the periodic distance of the shish-kebab structure is 100 nm to 600 nm.

[0018] According to some embodiments of the present invention, the raw materials for preparing the composite micro-nano fiber membrane material may further include nano magnesium oxide.

[0019] According to some embodiments of the invention, the molecular weight of the polycaprolactone is 80,000.

[0020] The second aspect of the present invention provides a method for preparing a composite micro-nano fiber membrane material having a shish-kebab structure, the preparation method comprising the following steps:

[0021] S1, dissolving polycaprolactone in a solvent to prepare a spinning solution, and electrospinning to prepare a micro-nano fiber film;

[0022] S2, immersing the micro-nano fiber film in a dilute polycaprolactone solution to induce crystallization;

[0023] S3, mixing the crystallized micro-nano fiber film, dopamine hydrochloride solution and antibacterial agent to obtain the composite micro-nano fiber membrane material.

[0024] According to some embodiments of the present invention, in step S1, the solvent is at least one of hexafluoroisopropanol, dichloromethane, N,N-dimethylformamide, tetrahydrofuran, chloroform, acetic acid, ethanol and trifluoroethanol.

[0025] According to some embodiments of the present invention, in step S1, the concentration of the nano magnesium oxide in the spinning solution is 0-5% w / v.

[0026] According to some embodiments of the present invention, in step S1, the concentration of the polycaprolactone in the spinning solution is 10-20% w / v.

[0027] According to some embodiments of the present invention, in step S1, the voltage of the electrospinning is 10-20 kV.

[0028] According to some embodiments of the present invention, in step S1, the receiving distance of the electrospinning is 10 to 20 cm.

[0029] According to some embodiments of the present invention, in step S1, the electrospinning solution advancing speed is 1-2 ml / h.

[0030] According to some embodiments of the present invention, in step S1, the rotation speed of the electrospinning collector is 100 to 2000 rpm / min.

[0031] According to some embodiments of the present invention, in step S2, the polycaprolactone dilute solution is obtained by diluting the polycaprolactone solution described in step S1.

[0032] According to some embodiments of the present invention, in step S2, the mass fraction of polycaprolactone in the polycaprolactone dilute solution is 0.1% to 2%.

[0033] According to some embodiments of the present invention, in step S2, the solvent of the polycaprolactone dilute solution is acetic acid or amyl acetate.

[0034] According to some embodiments of the present invention, in step S2, the time for inducing crystallization is 10 min to 24 h.

[0035] According to some embodiments of the present invention, in step S3, the concentration of the dopamine hydrochloride solution is 1-2 mg / mL.

[0036] According to some embodiments of the present invention, in step S3, the concentration of the antimicrobial agent is 0.001-5% w / v.

[0037] According to some embodiments of the present invention, in step S3, the antibacterial agent includes at least one of levofloxacin, erythromycin, azithromycin, antibacterial polypeptides and mixtures thereof.

[0038] According to some embodiments of the present invention, in step S3, the step of mixing the crystallized micro-nano fiber film with the dopamine hydrochloride solution further comprises: incubating in a constant temperature incubator shaker and performing ultrasonic cleaning until the cleaning solution does not change color.

[0039] According to some embodiments of the present invention, in step S3, the incubation temperature is a constant temperature of 35-38°C.

[0040] According to some embodiments of the present invention, in step S3, the incubation time is 10 to 15 hours.

[0041] According to some embodiments of the present invention, in step S3, the speed of the shaking table is 50-70 r / min.

[0042] The third aspect of the present invention provides the application of the above composite micro-nano fiber membrane material in the field of tissue engineering applications.

[0043] According to some embodiments of the present invention, the composite micro-nano fiber membrane material is used to prepare a tissue engineering scaffold, a drug sustained-release carrier, a bone transplant substitute or a wound treatment membrane.

[0044] Other features and advantages of the present invention will be set forth in the description which follows, and in part will be apparent from the description, or may be learned by practice of the present invention. BRIEF DESCRIPTION OF THE DRAWINGS

[0045] The above and / or additional aspects and advantages of the present invention will become apparent and easily understood from the description of the embodiments in conjunction with the following drawings, in which:

[0046] Figure 1 These are SEM images of the composite micro-nano fiber membrane materials in Examples 1, 2, and 3 of the present invention; wherein (a) is Example 1, (b) is Example 2, and (c) is Example 3;

[0047] Figure 2 is a SEM image of the composite micro-nano fiber membrane material in Example 4 of the present invention;

[0048] Figure 3is a SEM image of the composite micro-nano fiber membrane material in Example 5 of the present invention;

[0049] Figure 4 This is a picture of the antibacterial zone of the composite micro-nano fiber membrane material in Example 2 of the present invention;

[0050] Figure 5 is a comparison diagram of the diameters of the antibacterial zones of the composite micro-nano fiber membrane materials in Examples 1, 2, and 3 of the present invention;

[0051] Figure 6 This is a picture of the antibacterial zone of the composite micro-nano fiber membrane material in Example 4 of the present invention;

[0052] Figure 7 It is a comparison diagram of the contact angles of the composite micro-nano fiber membrane materials in Examples 1, 2, and 3 of the present invention. DETAILED DESCRIPTION

[0053] The following will be combined with the embodiments to clearly and completely describe the concept of the present invention and the technical effects produced, so as to fully understand the purpose, characteristics and effects of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, other embodiments obtained by those skilled in the art without creative work are all within the scope of protection of the present invention.

[0054] In the description of the present invention, if there is a description of first, second, etc., it is only for the purpose of distinguishing technical features, and cannot be understood as indicating or implying relative importance or implicitly indicating the number of the indicated technical features or implicitly indicating the order of the indicated technical features.

[0055] When a numerical range is disclosed herein, the above range is considered to be continuous and includes the minimum and maximum values ​​of the range, as well as every value between such minimum and maximum values. Further, when a range refers to an integer, every integer between the minimum and maximum values ​​of the range is included. In addition, when multiple ranges are provided to describe features or characteristics, the ranges can be combined. In other words, unless otherwise indicated, all ranges disclosed herein should be understood to include any and all subranges included therein.

[0056] The following will be combined with the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of the present invention.

[0057] Unless otherwise specified, the reagents, methods and equipment used in the present invention are conventional reagents, methods and equipment in the art.

[0058] Example 1

[0059] This embodiment provides a composite micro-nano fiber membrane material with a shish-kebab structure, and the preparation method thereof has the following steps:

[0060] A polycaprolactone spinning solution with a concentration of 12% was prepared to prepare a micro-nano fiber film under the electrospinning parameters of a voltage of 20 kV, a spinning solution propulsion speed of 2 ml / h, a receiving distance of 15 cm and a receiver rotation speed of 800 rpm / min.

[0061] The film was placed in a 0.5% polycaprolactone acetate solution to induce crystallization for 15 minutes. Then the crystallized film was placed in a 2mg / mL dopamine hydrochloride solution and incubated in a constant temperature shaker at 37°C and 60r / min for 12 hours. The film was taken out and ultrasonically cleaned until the aqueous solution did not change color. Finally, the sample was placed in a 0.1% levofloxacin aqueous solution for 8 hours. The obtained sample was dried to obtain a composite micro-nano fiber membrane material with a shredded crystal structure. Its morphology is shown in the figure. Figure 1 (a).

[0062] Example 2

[0063] This embodiment provides a composite micro-nano fiber membrane material with a shish-kebab structure, and the preparation method thereof has the following steps:

[0064] A polycaprolactone spinning solution with a concentration of 14% was prepared to prepare a micro-nano fiber film under the electrospinning parameters of a voltage of 20 kV, a spinning solution propulsion speed of 2 ml / h, a receiving distance of 15 cm and a receiver rotation speed of 800 rpm / min.

[0065] The film was placed in a 0.5% polycaprolactone acetate solution to induce crystallization for 15 minutes. Then the crystallized film was placed in a 2mg / mL dopamine hydrochloride solution and incubated in a constant temperature shaker at 37°C and 60r / min for 12 hours. The film was taken out and ultrasonically cleaned until the aqueous solution did not change color. Finally, the sample was placed in a 0.1% levofloxacin aqueous solution for 8 hours. The obtained sample was dried to obtain a composite micro-nano fiber membrane material with a shredded crystal structure. Its morphology is shown in the figure. Figure 1 (b).

[0066] Example 3

[0067] This embodiment provides a composite micro-nano fiber membrane material with a shish-kebab structure, and the preparation method thereof has the following steps:

[0068] A polycaprolactone spinning solution with a concentration of 17% was prepared to prepare a micro-nano fiber film under the electrospinning parameters of a voltage of 20 kV, a spinning solution propulsion speed of 2 ml / h, a receiving distance of 15 cm and a receiver rotation speed of 800 rpm / min.

[0069] The film was placed in a 0.5% polycaprolactone acetate solution to induce crystallization for 15 minutes. Then the crystallized film was placed in a 2mg / mL dopamine hydrochloride solution and incubated in a constant temperature shaker at 37°C and 60r / min for 12 hours. The film was taken out and ultrasonically cleaned until the aqueous solution did not change color. Finally, the sample was placed in a 0.1% levofloxacin aqueous solution for 8 hours. The obtained sample was dried to obtain a composite micro-nano fiber membrane material with a shredded crystal structure. Its morphology is shown in the figure. Figure 1 (c).

[0070] Example 4

[0071] This embodiment provides a composite micro-nano fiber membrane material with a shish-kebab structure, and the preparation method thereof has the following steps:

[0072] The spinning solution was prepared with a polycaprolactone concentration of 17% and a nano-magnesium oxide concentration of 2%. The micro-nano fiber film was prepared under the electrospinning parameters of 20 kV voltage, 2 ml / h spinning solution propulsion speed, 15 cm receiving distance and 100 rpm / min receiver rotation speed.

[0073] The film was placed in a 1% polycaprolactone acetate solution to induce crystallization for 18 hours. Then the crystallized film was placed in a 2mg / mL dopamine hydrochloride solution and incubated in a constant temperature shaker at 37°C and 60r / min for 12 hours. The film was taken out and ultrasonically cleaned until the aqueous solution did not change color. Finally, the sample was placed in a 0.05% levofloxacin aqueous solution for 8 hours. The obtained sample was dried to obtain a composite micro-nano fiber membrane material with a skewers structure. Its morphology is shown in the figure. Figure 2 .

[0074] Example 5

[0075] This embodiment provides a composite micro-nano fiber membrane material with a shish-kebab structure, and the preparation method thereof has the following steps:

[0076] The spinning solution was prepared with a polycaprolactone concentration of 17% and a nano-magnesium oxide concentration of 3.5%. The micro-nano fiber film was prepared under the electrospinning parameters of 20 kV voltage, 2 ml / h spinning solution propulsion speed, 15 cm receiving distance and 800 rpm / min receiver rotation speed.

[0077] The film was placed in a 1% polycaprolactone acetate solution to induce crystallization for 12 hours. Then the crystallized film was placed in a 2mg / mL dopamine hydrochloride solution and incubated in a constant temperature shaker at 37°C and 60r / min for 12 hours. The film was taken out and ultrasonically cleaned until the aqueous solution did not change color. Finally, the sample was placed in a 0.1% levofloxacin aqueous solution for 8 hours. The obtained sample was dried to obtain a composite micro-nano fiber membrane material with a shredded crystal structure. Its morphology is shown in the figure. Figure 3 .

[0078] Comparative Example 1

[0079] This comparative example provides a composite film material, which is different from Example 4 in that no induced crystallization is performed, and the micro-nano fiber film is directly placed in the dopamine hydrochloride solution.

[0080] Test Example 1

[0081] Antibacterial test: The antibacterial activity of the samples was tested using the antibacterial zone method. The samples were cut into 1×1 cm slices (4 slices per group of samples) under sterile conditions. The bacterial density was adjusted to 1-5×10 6 CFU / mL, 100 μL of bacterial solution was evenly applied on LB agar plate. Then the sample was carefully placed on the agar plate and cultured at 37°C for 24 hours before observing and measuring the diameter of the inhibition zone.

[0082] The inhibition zones of Examples 1 to 3 against Escherichia coli, and the inhibition zones of Examples 4 to 5 and Comparative Example 1 against Staphylococcus aureus were tested.

[0083] According to the comparison of the morphology images of Examples 1 to 2, it can be seen that the PCL concentration has an effect on the size of its crystal lamellae. In comparison, the 14% PCL shredded crystal structure is the most obvious. Combined with the comparison of the morphology images of Examples 4 and 5, the shredded crystal structure with the addition of nano-magnesium oxide is more obvious, and the lamellae size is larger. As the concentration increases, the lamellae size increases and the crystal density also increases.

[0084] Comparison of the diameters of the inhibition zones of Escherichia coli in Examples 1 to 3 shows that the diameter of the inhibition zone of the sample in Example 2 is the largest. Figure 4 As shown, it shows that the shuffle structure of the film can better adsorb the antibacterial agent, thus having a more significant antibacterial effect. The comparison results are shown in Figure 5 The average diameter of the antibacterial zone of the sample in Example 4 against Staphylococcus aureus is 34.4 mm, and the average diameter of the antibacterial zone of the sample in Comparative Example 1 against Staphylococcus aureus is 30.6 mm. By comparing Example 4 with Comparative Example 1, it can be seen that the antibacterial effect of the non-crystallized film is significantly lower than that of the film with a kebab microstructure. The antibacterial zone picture of Example 4 is shown in FIG. Figure 6 shown.

[0085] Test Example 2

[0086] Hydrophilicity test: Use a contact angle tester to test the hydrophilicity of the sample. First, cut the sample into the size of a glass slide, fix the front of the sample flatly on the PTFE gasket, select the horizontal plane and perform baseline correction, enter the sample size, and test the contact angle of the sample. Drop 10uL of deionized water vertically on the sample surface. The sampling time is 10s. Use the angle measurement method to measure the contact angle, and use the corresponding software to record the experimental results in real time. Take five different positions for each sample for measurement, and take the average value as the contact angle value.

[0087] It can be seen from Examples 1 to 3 that the contact angle values ​​after crystallization are all reduced to below 90°, and the hydrophilicity of the material is greatly improved. Figure 7 shown.

[0088] The present invention uses a dilute solution of polycaprolactone to self-induced crystallization of the spinning membrane, and utilizes adsorption to modify the surface of the crystallized membrane material, thereby obtaining a composite micro-nano fiber membrane material with a shuffle microstructure, thereby increasing the specific surface area of ​​the film, thereby greatly improving the hydrophilicity of the polycaprolactone membrane and the antibacterial activity.

[0089] The above is a detailed description of the embodiments of the present invention, but the present invention is not limited to the above embodiments. Various changes can be made within the knowledge of ordinary technicians in the relevant technical field without departing from the purpose of the present invention. In addition, the embodiments of the present invention and the features in the embodiments can be combined with each other without conflict.

Claims

1. A composite micro-nano fiber membrane material with a shish-kebab structure, characterized in that: The raw materials for preparing the composite micro-nano fiber membrane material include polycaprolactone, dopamine hydrochloride solution and antibacterial agent; Wherein, the composite micro-nano fiber membrane material is a shredded crystal structure with spirally staggered arrangement along the diameter direction of the nanofiber.

2. The composite micro-nano fiber membrane material according to claim 1, characterized in that: The lamella size of the shish-kebab structure is 10 nm to 700 nm; preferably, the periodic distance of the shish-kebab structure is 20 nm to 2000 nm; preferably, the raw material for preparing the composite micro-nano fiber membrane material may also include nano magnesium oxide.

3. A method for preparing the composite micro-nano fiber membrane material according to any one of claims 1 to 2, characterized in that: The preparation method comprises the following steps: S1, dissolving polycaprolactone in a solvent to prepare a spinning solution, and electrospinning to prepare a micro-nano fiber film; S2, immersing the micro-nano fiber film in a dilute polycaprolactone solution to induce crystallization; S3, mixing the crystallized micro-nano fiber film, dopamine hydrochloride solution and antibacterial agent to obtain the composite micro-nano fiber membrane material.

4. The preparation method according to claim 3, characterized in that: In step S1, the concentration of the polycaprolactone in the spinning solution is 10-20% w / v; preferably, in step S1, the concentration of the nano magnesium oxide in the spinning solution is 0-5% w / v; preferably, in step S1, at least one of hexafluoroisopropanol, dichloromethane, N,N-dimethylformamide, tetrahydrofuran, chloroform, acetic acid, ethanol, and trifluoroethanol.

5. The preparation method according to claim 3, characterized in that: In step S1, the voltage of the electrospinning is 10-20 kV; preferably, in step S1, the receiving distance of the electrospinning is 10-20 cm; preferably, in step S1, the electrospinning liquid propulsion speed is 1-2 ml / h; preferably, in step S1, the collector speed of the electrospinning is 100-2000 rpm / min.

6. The preparation method according to claim 3, characterized in that: In step S2, the polycaprolactone dilute solution is obtained by diluting the polycaprolactone solution described in step S1; preferably, in step S2, the mass fraction of polycaprolactone in the polycaprolactone dilute solution is 0.1% to 2%; preferably, in step S2, the solvent of the polycaprolactone dilute solution is acetic acid or amyl acetate; preferably, in step S2, the time for inducing crystallization is 10 min to 24 h.

7. The preparation method according to claim 3, characterized in that: In step S3, the concentration of the dopamine hydrochloride solution is 1-2 mg / mL; preferably, in step S3, the concentration of the antibacterial agent is 0.001-5% w / v; preferably, in step S3, the antibacterial agent includes at least one of levofloxacin, erythromycin, azithromycin, antibacterial polypeptides and mixtures thereof.

8. The preparation method according to claim 3, characterized in that: In step S3, the step of mixing the crystallized micro-nano fiber film with the dopamine hydrochloride solution further comprises: incubating in a constant temperature culture shaker and performing ultrasonic cleaning until the cleaning solution does not change color.

9. The preparation method according to claim 8, characterized in that: In step S3, the incubation temperature is a constant temperature of 35-38°C; preferably, in step S3, the incubation time is 10-15h; preferably, in step S3, the shaking speed is 50-70r / min.

10. Use of the composite micro-nano fiber membrane material according to any one of claims 1 to 2 in the field of tissue engineering applications.